Ethyl 2-((diethoxyphosphoryl)methylamino)acetate → ethyl 2-(3-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)-N-((diethoxyphosphoryl)methyl)phenylsulfonamido)acetate

HRID 870141Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 870141
[CH2:1]([O:3][P:4]([CH2:9][NH:10][CH2:11][C:12]([O:14][CH2:15][CH3:16])=[O:13])([O:6][CH2:7][CH3:8])=[O:5])[CH3:2].[Cl:17][C:18]1[CH:19]=[C:20]2[C:25](=[C:26]([Cl:28])[CH:27]=1)[CH2:24][N:23]([CH3:29])[CH2:22][CH:21]2[C:30]1[CH:31]=[C:32]([S:36](Cl)(=[O:38])=[O:37])[CH:33]=[CH:34][CH:35]=1>N1C=CC=CC=1>[Cl:17][C:18]1[CH:19]=[C:20]2[C:25](=[C:26]([Cl:28])[CH:27]=1)[CH2:24][N:23]([CH3:29])[CH2:22][CH:21]2[C:30]1[CH:31]=[C:32]([S:36]([N:10]([CH2:11][C:12]([O:14][CH2:15][CH3:16])=[O:13])[CH2:9][P:4]([O:3][CH2:1][CH3:2])([O:6][CH2:7][CH3:8])=[O:5])(=[O:38])=[O:37])[CH:33]=[CH:34][CH:35]=1

Komponenten

4

Versuchsvorschrift

Into a 50-mL round-bottom flask, was placed a solution of ethyl 2-((diethoxyphosphoryl)methylamino)acetate (320 mg, 1.26 mmol, 1.00 equiv) in pyridine (10 mL). 3-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)benzene-1-sulfonyl chloride (500 mg, 1.28 mmol, 1.01 equiv) was added and the resulting solution was stirred overnight at room temperature. The reaction progress was monitored by LCMS. The resulting mixture was concentrated under vacuum. The crude product (400 mg) was purified by preparative HPLC to give 200 mg (24%) of the title compound as a TFA salt.

Aufarbeitung

  1. customInto a 50-mL round-bottom flask, was placed
  2. concentrationThe resulting mixture was concentrated under vacuum
  3. customThe crude product (400 mg) was purified by preparative HPLC

Quellen und Nachweise

ORD-Eintrag
ord-ce20b0f50a5c4fc99d3f32530f45cfea
Quelldatensatz
uspto-grants-2015_03
Patentnummer
US08969377B2

Notizen zur Reaktion

Wird geladen…